BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23705810)

  • 1. 4th Annual Predictive Toxicology Summit 2012.
    Cui Z
    Expert Opin Drug Metab Toxicol; 2013 Aug; 9(8):1061-6. PubMed ID: 23705810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy'': stem cells and cell-cell communication as fundamental targets in assessing the potential toxicity of chemicals.
    Trosko JE
    Hum Exp Toxicol; 2010 Jan; 29(1):21-9. PubMed ID: 20061464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Good cell culture practices &in vitro toxicology.
    Eskes C; Boström AC; Bowe G; Coecke S; Hartung T; Hendriks G; Pamies D; Piton A; Rovida C
    Toxicol In Vitro; 2017 Dec; 45(Pt 3):272-277. PubMed ID: 28450071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell models for drug discovery and toxicology studies.
    Liu W; Deng Y; Liu Y; Gong W; Deng W
    J Biochem Mol Toxicol; 2013 Jan; 27(1):17-27. PubMed ID: 23293059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of in vitro model systems in toxicology.
    Davila JC; Rodriguez RJ; Melchert RB; Acosta D
    Annu Rev Pharmacol Toxicol; 1998; 38():63-96. PubMed ID: 9597149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical toxicology: designing studies to reduce animal use, while maximizing human translation.
    Chapman KL; Holzgrefe H; Black LE; Brown M; Chellman G; Copeman C; Couch J; Creton S; Gehen S; Hoberman A; Kinter LB; Madden S; Mattis C; Stemple HA; Wilson S
    Regul Toxicol Pharmacol; 2013 Jun; 66(1):88-103. PubMed ID: 23524271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicology in the 21st century--working our way towards a visionary reality.
    Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
    Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Schwartz SL
    Hum Exp Toxicol; 2010 Jan; 29(1):15-9. PubMed ID: 20061463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternatives to animal experimentation in basic research.
    Gruber FP; Hartung T
    ALTEX; 2004; 21 Suppl 1():3-31. PubMed ID: 15586255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative methods for ocular toxicology testing: validation, applications and troubleshooting.
    Dholakiya SL; Barile FA
    Expert Opin Drug Metab Toxicol; 2013 Jun; 9(6):699-712. PubMed ID: 23527818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative test methods in inhalation toxicology: challenges and opportunities.
    Costa DL
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):105-9. PubMed ID: 18486462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of stem cells as alternative methods to animal experimentation in predictive toxicology.
    Kim TW; Che JH; Yun JW
    Regul Toxicol Pharmacol; 2019 Jul; 105():15-29. PubMed ID: 30930176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Phalen RF
    Hum Exp Toxicol; 2010 Jan; 29(1):11-4. PubMed ID: 20061462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview: developmental toxicology: new directions.
    Shuey D; Kim JH
    Birth Defects Res B Dev Reprod Toxicol; 2011 Oct; 92(5):381-3. PubMed ID: 21770024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation.
    De Wever B; Fuchs HW; Gaca M; Krul C; Mikulowski S; Poth A; Roggen EL; Vilà MR
    Toxicol In Vitro; 2012 Apr; 26(3):526-34. PubMed ID: 22269383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental toxicity testing in the 21st century: the sword of Damocles shattered by embryonic stem cell assays?
    Seiler A; Oelgeschläger M; Liebsch M; Pirow R; Riebeling C; Tralau T; Luch A
    Arch Toxicol; 2011 Nov; 85(11):1361-72. PubMed ID: 22008952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell-derived systems in toxicology assessment.
    Suter-Dick L; Alves PM; Blaauboer BJ; Bremm KD; Brito C; Coecke S; Flick B; Fowler P; Hescheler J; Ingelman-Sundberg M; Jennings P; Kelm JM; Manou I; Mistry P; Moretto A; Roth A; Stedman D; van de Water B; Beilmann M
    Stem Cells Dev; 2015 Jun; 24(11):1284-96. PubMed ID: 25675366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How omics technologies can contribute to the '3R' principles by introducing new strategies in animal testing.
    Kroeger M
    Trends Biotechnol; 2006 Aug; 24(8):343-6. PubMed ID: 16782220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.